Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Obesity
Fierce Pharma
Novo, Lilly obesity meds 'highly cost-effective': ICER report
ICER has high confidence in the drugs' cost-effectiveness but also voiced concerns over the drugs' impact on healthcare budgets.
Eric Sagonowsky
Sep 9, 2025 10:30am
Hims & Hers stock drops 30% after Novo Nordisk terminates deal
Jun 23, 2025 12:00pm
How much GLP-1 prescriptions for weight management have grown
May 28, 2025 1:03pm
CMS excludes anti-obesity drug coverage under Medicare, Medicaid
Apr 4, 2025 4:28pm
Omada partners with CVS Caremark on weight management program
Mar 28, 2025 4:45pm
Industry Voices—The GLP-1 status quo is no longer acceptable
Mar 7, 2025 8:47am
